332 related articles for article (PubMed ID: 8636301)
1. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro.
Roe CM; Leitch IM; Boura AL; Smith R
J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibits corticotropin-releasing hormone exocytosis but not synthesis by cultured human trophoblasts.
Ni X; Chan EC; Fitter JT; Smith R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4171-5. PubMed ID: 9398734
[TBL] [Abstract][Full Text] [Related]
3. Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension.
Donoghue JF; Leitch IM; Boura AL; Walters WA; Giles WB; Smith R; Read MA
Placenta; 2000 Sep; 21(7):711-7. PubMed ID: 10985975
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway.
Clifton VL; Read MA; Leitch IM; Giles WB; Boura AL; Robinson PJ; Smith R
J Clin Endocrinol Metab; 1995 Oct; 80(10):2888-93. PubMed ID: 7559870
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation.
Clifton VL; Read MA; Leitch IM; Boura AL; Robinson PJ; Smith R
J Clin Endocrinol Metab; 1994 Aug; 79(2):666-9. PubMed ID: 8045990
[TBL] [Abstract][Full Text] [Related]
6. Basal and KCl-stimulated corticotropin-releasing hormone release from human placental syncytiotrophoblasts is inhibited by sodium nitroprusside.
Sun K; Smith R; Robinson PJ
J Clin Endocrinol Metab; 1994 Aug; 79(2):519-24. PubMed ID: 7913933
[TBL] [Abstract][Full Text] [Related]
7. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature.
Wieczorek KM; Brewer AS; Myatt L
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):708-13. PubMed ID: 7573230
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
Margioris AN; Grino M; Protos P; Gold PW; Chrousos GP
J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
Leitch IM; Read MA; Boura AL; Walters WA
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):615-22. PubMed ID: 7529152
[TBL] [Abstract][Full Text] [Related]
10. Vascular responses to sodium nitroprusside in the human fetal-placental circulation.
Read MA; Giles WB; Leitch IM; Boura AL; Walters WA
Reprod Fertil Dev; 1995; 7(6):1557-61. PubMed ID: 8743164
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of glucocorticoids in the human fetal-placental circulation in vitro.
Clifton VL; Wallace EM; Smith R
J Clin Endocrinol Metab; 2002 Jun; 87(6):2838-42. PubMed ID: 12050259
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
Bugajski J; Borycz J; Gadek-Michalska A; Głód R
J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
[TBL] [Abstract][Full Text] [Related]
13. Adrenocorticotropin causes vasodilatation in the human fetal-placental circulation.
Clifton VL; Read MA; Boura AL; Robinson PJ; Smith R
J Clin Endocrinol Metab; 1996 Apr; 81(4):1406-10. PubMed ID: 8636342
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation.
Myatt L; Brewer AS; Langdon G; Brockman DE
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):224-30. PubMed ID: 1733199
[TBL] [Abstract][Full Text] [Related]
15. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro.
Leitch IM; Boura AL; Botti C; Read MA; Walters WA; Smith R
J Clin Endocrinol Metab; 1998 Dec; 83(12):4510-3. PubMed ID: 9851801
[TBL] [Abstract][Full Text] [Related]
16. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides.
Karteris E; Vatish M; Hillhouse EW; Grammatopoulos DK
J Clin Endocrinol Metab; 2005 Jun; 90(6):3680-7. PubMed ID: 15784708
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone in baboon pregnancy.
Smith R; Chan EC; Bowman ME; Harewood WJ; Phippard AF
J Clin Endocrinol Metab; 1993 Apr; 76(4):1063-8. PubMed ID: 8473382
[TBL] [Abstract][Full Text] [Related]
18. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
19. Secretion of corticotropin-releasing hormone by superfused human placental fragments.
Thomson M; Chan EC; Falconer J; Madsen G; Smith R
Gynecol Endocrinol; 1988 Jun; 2(2):87-100. PubMed ID: 3263748
[TBL] [Abstract][Full Text] [Related]
20. Response to corticotropin-releasing hormone during pregnancy in the baboon.
Goland RS; Stark RI; Wardlaw SL
J Clin Endocrinol Metab; 1990 Apr; 70(4):925-9. PubMed ID: 2156891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
